Biosimilars Portfolio
![Biosimilars Portfolio](/46/product/129/50/29/CuraTeQ%20Biosimilars%20Pipelilne.jpg)
Product Description
CuraTeQ Biologics
![CuraTeQ Biologics](/CuraTeQ%20Logo%20Final-comp321484.png)
-
IN
-
2024On CPHI since
-
250 - 499Employees
Company types
Primary activities
Categories
CuraTeQ Biologics
![CuraTeQ Biologics](/CuraTeQ%20Logo%20Final-comp321484.png)
-
IN
-
2024On CPHI since
-
250 - 499Employees
Company types
Primary activities
More Products from CuraTeQ Biologics (1)
-
Product Synthetic Peptide APIs Portfolio
US DMF Approved: • Vasopressin • Icatibant acetate • Leuprolide acetate • Linaclotide • Etelcalcetide • Desmopressin US DMF Filed: • Calcitonin salmon • Ganirelix acetate • Degarelix • Glatiramer acetate • Plecanatide • Teriparat...
CuraTeQ Biologics resources (1)
-
Brochure Synthetic Peptide APIs Portfolio
Auro Peptides, our synthetic peptides arm, has filed 14 US DMFs which have contributed to 6 ANDA approvals.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance